Active Ingredient(s):Velaglucerase Alfa FDA Approved: * February 26, 2010 Pharm Company: *SHIRE Category:Enzymes
Velaglucerase alfa, sold under the brand name Vpriv and manufactured by Shire plc, is a hydrolytic lysosomal glucocerebroside-specific enzyme, which is a recombinant form of glucocerebrosidase indicated as a long-term enzyme replacement therapy for those suffering of Gaucher disease Type 1. It has an identical amino acid sequence to the naturally occurring enzyme. It was approved for use by the U.S. Food and Drug Administration (FDA) on February 26, 2010....
* May have multiple approval dates, manufacturers, or labelers.
Vpriv 2.5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution